Independent Director · Mersana Therapeutics, Inc. (MRSN)

Allene M. Diaz director compensation at Mersana Therapeutics: $151K

Fiscal year 2024 director compensation for Allene M. Diaz at Mersana Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Allene M. Diaz’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Allene M. Diaz and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Mersana Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Mersana Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$45,000—$105,996—$150,996
FY2022$45,000—$119,192—$164,192
FY2021$36,625—$499,908—$536,533

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Mersana Therapeutics, Inc. DEF 14A filed April 29, 2025, accession 0001104659-25-040448, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Mersana Therapeutics, Inc. filed document, accession 0001104659-25-040448. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.

Get the Mersana Therapeutics Board Governance Report

$150,996 Allene M. Diaz, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

Mersana Therapeutics pays directors a $40,000 cash retainer and $105,996 in Options.

Committees

FY2024 · as the proxy prints them

Audit · Compensation

The rest of the Mersana Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Andrew A. F. Hack, M.D., Ph.DIndependent Director$153,496
Anna ProtopapasDirector$145,996
David MottChair of the Board$185,996
Kristen M. Hege, M.DIndependent Director$154,996
Lawrence M. AllevaIndependent Director$164,996
Martin Huber, M.DDirector—
Willard Dere, M.DIndependent Director$161,496

The full Mersana Therapeutics compensation record

free company brief

This page is one director within Mersana Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Mersana Therapeutics proxy · each links to its own free brief

Order MRSN

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report